News

The National Institute for Health and Care Excellence (NICE) is to consider the US approach to treating people with depression, following new research showing that the treatment model could be successfully replicated in the UK.

US-based contract research organisation WCCT Global is leveraging its expertise in ethnobridging and diabetes studies to address the rapid spread of Type 2 Diabetes Mellitus (T2DM) in China and the drug-development needs of the local pharmaceutical industry.

MD On-Line (MDOL), a US-based provider of eHealthcare solutions such as electronic data interchange and electronic medical records systems, is now turning its attention to physician-driven patient recruitment for clinical trials.

The Indian government has announced plans to amend its policy on foreign direct investment (FDI) in the pharmaceutical sector in order to protect domestic generics makers from acquisition by foreign multinationals.

Johnson & Johnson has completed its $1-billion purchase of private US cancer drug development firm Aragon Pharmaceuticals.

Litera, a US-based provider of content lifecycle-management solutions, has expanded its portfolio by acquiring the AxxiTRIALS clinical-trials portal from web technology specialist Axxiem Web Solutions.

UK patients with a certain type of skin cancer can now get access to Roche’s once-daily pill Erivedge following its launch in the country.

Shire has retained investment bank Lazard to help it prepare for a possible takeover attempt, says a Sunday Times report.

Physiotherapists and podiatrists in the UK will become the first in the world able to independently prescribe medication to their patients, in a move designed to speed up access to treatment and free up GPs’ time.

Regulators have approved a combination of GlaxoSmithKline’s Tyverb and Roche’s Herceptin for use within the European Union, offering a new chemo-free option for the treatment of metastatic breast cancer.

Eli Lilly is due to start the defense of its blockbuster lung cancer therapy Alimta in a US district court later today in a bid to keep exclusivity for the product until 2022.

The development of genomics for public health is being prioritised mainly by low- and middle-income nations, with richer countries not seeking to collaborate in such research, reports the Organisation for Economic Cooperation and Development (OECD).

German drugmaker Stada has finalised its acquisition of UK over-the-counter drugmaker Thornton & Ross in a deal valued at £221 million.

The Royal College of General Practitioners has requested an injection of emergency funds to help tackle the “double whammy of spiralling workloads and dwindling resources” facing GPs.

The stress associated with providing unpaid care for a sick or disabled adult is leading to a 29% greater use of anti-anxiety medicines among such caregivers, compared those who do not provide such care, a US study has found.